Riyadh, Saudi Arabia — Nahdi Medical Company posted a net profit of SAR 493.6 million for the first half of 2025, a 2.7% increase from SAR 480.7 million in H1 2024, according to its Tadawul filing.

Retail and Healthcare Drive Revenue Gains

Total revenue grew 9.1% year-on-year to SAR 5.16 billion. This was driven by retail strength and significant growth in healthcare and the UAE markets. Retail revenue rose 7.3%, while the healthcare and UAE segments expanded 82.2% and 41.4%, respectively.

In Q2 2025, revenue reached SAR 2.53 billion, up 2.2% year-on-year but down 4.1% from Q1 due to seasonal trends. Quarterly net profit fell 3.8% year-on-year to SAR 238.4 million and was down 6.6% from Q1, mainly due to higher costs from business growth.

Gross profit improved to SAR 966 million in Q2, supported by a favorable retail mix. Operating profit declined 4.7% to SAR 260.6 million. However, operating expenses fell to 27.1% of revenue, down from 27.5% a year earlier, reflecting better cost control.

Total comprehensive income for H1 was SAR 492.4 million, slightly below the SAR 505.1 million recorded in H1 2024, due to end-of-service actuarial adjustments.

Nahdi reaffirmed its use of Shariah-compliant finance across its growing regional operations.

What This Means for Investors

  • Segment strength: Healthcare and UAE growth helped offset seasonal retail softness.
  • Improved efficiency: Expense ratios declined even as expansion raised costs.
  • Ethical finance: Shariah compliance continues to appeal to faith-driven investors.
  • Growth outlook: Ongoing store launches and digital upgrades support long-term performance.

 

THE SAUDI STANDARD’S VIEW: Nahdi Medical H1 2025 Profit Reflects Strategic Balance and Retail Strength

The SAR 493.6 million Nahdi Medical H1 2025 profit highlights the company’s resilience and steady growth amid ongoing expansion and seasonal shifts.

A 9.1% revenue gain shows strong execution across key business lines, especially in healthcare and the UAE. This confirms the effectiveness of Nahdi’s geographic and service diversification.

Though Q2 profit dipped due to expansion costs, improved gross margins and lower expense ratios indicate strong cost control and operational agility.

Nahdi’s continued investment in digital systems and new store openings aligns with Vision 2030. It also reinforces the company’s role in expanding access to healthcare and modern retail services.

With Shariah-compliant practices and growing investor confidence, Nahdi remains a model of balanced, ethical growth. The Nahdi Medical H1 2025 profit reflects not just solid performance but also the company’s growing importance in Saudi Arabia’s evolving consumer health landscape.

 

Related Reading

Browse the latest Saudi investment news and financial trends
Track earnings reports and investor updates from listed healthcare firms